MedTrace Logo

Developmental Dyslexia and Remediation Methods

NCT04028310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2023-09-29

No results posted yet for this study

Summary

At least, three theoretical frameworks are currently involved in therapeutic research in developmental dyslexia. Each theoretical framework relies on the type of underlying cognitive processes that is viewed as impaired: 1°) phonological processing, 2°) cross modal integration, 3°) visual attention processing. In this controlled and randomized study, three types of computerized training are combined in a multi-factorial remedial approach in 8 to 12 year old children with dyslexia. The main objective is to compare the effectiveness of this remedial approach which combines phonological, visual-attentional and cross-modal training with conventional non-intensive and non-specific rehabilitation

Conditions

  • Dyslexia, Developmental

Interventions

OTHER

Phonological

* Phase 1: intervention without targeted daily training (30 minutes/ week, for 8 weeks) * Phase 2: intervention with targeted daily training * Phonological training (15 minutes/ day, 5 days/week, for 8 weeks) * Visuo-attentional training (15 minutes/ day, 5 days/week, for 8 weeks) * Cross-modal training (15 minutes/ day, 5 days/week, for 8 weeks) * Phase 3: stopping training sessions for 8 weeks

OTHER

Visual-attention

* Phase 1: intervention without targeted daily training (30 minutes/ week, for 8 weeks) * Phase 2: intervention with targeted daily training * Visuo-attentional training (15 minutes/ day, 5 days/week, for 8 weeks) * Phonological training (15 minutes/ day, 5 days/week, for 8 weeks) * Cross-modal training (15 minutes/ day, 5 days/week, for 8 weeks) * Phase 3: stopping training sessions for 8 weeks

Sponsors & Collaborators

  • Fondation Lenval

    lead OTHER

Principal Investigators

  • HARRAR-ESKINAZI KARINE · CERTA Fondation Lenval, Children Hospital of Nice CHU-LENVAL

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-25
Primary Completion
2022-12-12
Completion
2022-12-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04028310 on ClinicalTrials.gov